These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 33315227)

  • 1. Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs.
    Platania CBM; Bucolo C
    Methods Mol Biol; 2021; 2253():245-254. PubMed ID: 33315227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting Functional Dynamics in Proteins with Comparative Perturbed-Ensembles Analysis.
    Yao XQ; Hamelberg D
    Acc Chem Res; 2019 Dec; 52(12):3455-3464. PubMed ID: 31793290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidden allosteric sites and De-Novo drug design.
    Rehman AU; Lu S; Khan AA; Khurshid B; Rasheed S; Wadood A; Zhang J
    Expert Opin Drug Discov; 2022 Mar; 17(3):283-295. PubMed ID: 34933653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPC Analysis of Multiple Binding Sites Communication and Allosteric Modulations in Drug Design: The HSP Case Study.
    Chiappori F; Milanesi L; Merelli I
    Curr Drug Targets; 2016; 17(14):1610-1625. PubMed ID: 26648062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
    Pandey P; Roy KK; Doerksen RJ
    J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of hidden allosteric sites as novel targets for allosteric drug design.
    Lu S; Ji M; Ni D; Zhang J
    Drug Discov Today; 2018 Feb; 23(2):359-365. PubMed ID: 29030241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are the Apo Proteins Suitable for the Rational Discovery of Allosteric Drugs?
    An X; Lu S; Song K; Shen Q; Huang M; Yao X; Liu H; Zhang J
    J Chem Inf Model; 2019 Jan; 59(1):597-604. PubMed ID: 30525607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperativity between the orthosteric and allosteric ligand binding sites of RORĪ³t.
    de Vries RMJM; Meijer FA; Doveston RG; Leijten-van de Gevel IA; Brunsveld L
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Computational Methods for the Rational Discovery of Allosteric Drugs.
    Wagner JR; Lee CT; Durrant JD; Malmstrom RD; Feher VA; Amaro RE
    Chem Rev; 2016 Jun; 116(11):6370-90. PubMed ID: 27074285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design.
    Huang W; Nussinov R; Zhang J
    Methods Mol Biol; 2017; 1529():439-446. PubMed ID: 27914066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revealing Atomic-Level Mechanisms of Protein Allostery with Molecular Dynamics Simulations.
    Hertig S; Latorraca NR; Dror RO
    PLoS Comput Biol; 2016 Jun; 12(6):e1004746. PubMed ID: 27285999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Dynamics-Markov State Model of Protein Ligand Binding and Allostery in CRIB-PDZ: Conformational Selection and Induced Fit.
    Thayer KM; Lakhani B; Beveridge DL
    J Phys Chem B; 2017 Jun; 121(22):5509-5514. PubMed ID: 28489401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational allosteric ligand binding site identification on Ras proteins.
    McCarthy M; Prakash P; Gorfe AA
    Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):3-10. PubMed ID: 26487442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding G Protein-Coupled Receptor Allostery via Molecular Dynamics Simulations: Implications for Drug Discovery.
    Basith S; Lee Y; Choi S
    Methods Mol Biol; 2018; 1762():455-472. PubMed ID: 29594786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Computational Approaches and Tools forAllosteric Drug Discovery.
    Sheik Amamuddy O; Veldman W; Manyumwa C; Khairallah A; Agajanian S; Oluyemi O; Verkhivker G; Tastan Bishop O
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markov models for the elucidation of allosteric regulation.
    Sengupta U; Strodel B
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1749):. PubMed ID: 29735732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple, yet powerful methodologies for conformational sampling of proteins.
    Harada R; Takano Y; Baba T; Shigeta Y
    Phys Chem Chem Phys; 2015 Mar; 17(9):6155-73. PubMed ID: 25659594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NRIMD, a Web Server for Analyzing Protein Allosteric Interactions Based on Molecular Dynamics Simulation.
    He Y; Wang S; Zeng S; Zhu J; Xu D; Han W; Wang J
    J Chem Inf Model; 2024 Oct; 64(19):7176-7183. PubMed ID: 38991149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling Allosteric Networks in Proteins.
    Dokholyan NV
    Chem Rev; 2016 Jun; 116(11):6463-87. PubMed ID: 26894745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.